Latest News

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Hyliion To Contact Him Directly To Discuss Their Options If you purchased or acquired

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In York To Contact Him Directly To Discuss Their Options If you purchased or acquired se

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Datavault AI To Contact Him Directly To Discuss Their Options If you purchased or acq

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Company Short Name To Contact Him Directly To Discuss Their Options If you purchased

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Cogent To Contact Him Directly To Discuss Their Options If you purchased or acquired

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Microvast To Contact Him Directly To Discuss Their Options If you purchased or acquir

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Capricor To Contact Him Directly To Discuss Their Options If you purchased or acquire

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In EquipmentShare To Contact Him Directly To Discuss Their Options If you purchased or a

Faruqi and Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Bloom Energy To Contact

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Wix To Contact Him Directly To Discuss Their Options If you purchased or acquired sec

Sandisk Corporation is initiated with a Buy rating and a $2,160 price target, driven by explosive revenue growth and exceptional margin expansion post-spin from Western Digital. Fiscal 2026 saw revenu

GSK NYSE: GSK is accelerating investment in research and development, expanding its late-stage pipeline and targeting cost savings to support product launches while maintaining profitability through u

Fed rate-hike odds hit 87.3% as traders watch oil, retail sales and key stock support before Wednesday's decision and Warsh's new policy projections for stocks.

North American Construction has transformed its business with the MacKellar and IMC acquisitions, shifting its earnings engine to Australia. Australia now contributes 75% of revenue, offering broader

Prudential Financial NYSE: PRU is narrowing its insurance-business geographic footprint, pursuing targeted acquisitions and reshaping its operating model as it seeks to increase growth, improve capita

Booking NASDAQ: BKNG Chief Financial Officer Ewout Steenbergen said the company's second-quarter performance reflected resilient travel demand, with booking trends improving from June after consumers

Market valuation indicators show the S&P 500 is overvalued by 121% to 227% based on August 2026 monthly data. The four valuation indicators' average sits at 172%, remaining over 3 standard deviations

Datadog NASDAQ: DDOG is investing in artificial intelligence capabilities, proprietary models and enterprise sales as it seeks to expand its observability platform's role in monitoring increasingly co

Keurig Dr Pepper is rated a Buy, driven by robust U.S. Refreshment Beverages growth and the accretive JDE Peet's acquisition. KDP's beverage segment delivers sustainable volume-led growth, with Dr Pep

Millrose Properties is rated Strong Buy, trading at 9x 2027 FFO with a 10%+ dividend yield and below book value. Growth beyond Lennar, especially in Other Agreements yielding 10.6%, is the core invest